Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy

Chimeric antigen receptor (CAR) T-cell therapy engineers T-cells to express a synthetic receptor which redirects effector function to the tumor, to improve efficacy and reduce toxicities associated with conventional treatments, such as radiotherapy and chemotherapy. This approach has proved effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Hawkins, Elizabeth R, D’Souza, Reena R, Klampatsa, Astero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053711/
https://www.ncbi.nlm.nih.gov/pubmed/33883875
http://dx.doi.org/10.2147/BTT.S291768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053711/
https://www.ncbi.nlm.nih.gov/pubmed/33883875
http://dx.doi.org/10.2147/BTT.S291768

Ejemplares similares